BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38755129)

  • 1. E3 ubiquitin ligase UBR5 promotes gemcitabine resistance in pancreatic cancer by inducing O-GlcNAcylation-mediated EMT via destabilization of OGA.
    Du Y; Yang Z; Shi H; Chen Z; Chen R; Zhou F; Peng X; Hong T; Jiang L
    Cell Death Dis; 2024 May; 15(5):340. PubMed ID: 38755129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα.
    Chen L; Yuan R; Wen C; Liu T; Feng Q; Deng X; Du Y; Peng X
    Oncogene; 2021 Jan; 40(2):262-276. PubMed ID: 33122826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition.
    Jin H; Zhao Y; Zhang S; Yang J; Zhang X; Ma S
    Mol Med Rep; 2018 May; 17(5):7274-7280. PubMed ID: 29568909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway.
    Xu F; Huang M; Chen Q; Niu Y; Hu Y; Hu P; Chen D; He C; Huang K; Zeng Z; Tang J; Wang F; Zhao Y; Wang C; Zhao G
    Cancer Res; 2021 Nov; 81(22):5678-5691. PubMed ID: 34593522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer.
    Fan K; Fan Z; Cheng H; Huang Q; Yang C; Jin K; Luo G; Yu X; Liu C
    Cancer Med; 2019 Oct; 8(13):5903-5915. PubMed ID: 31426130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0092367 Inhibits EMT and Gemcitabine Resistance in Pancreatic Cancer via Regulating the miR-1206/ESRP1 Axis.
    Yu S; Wang M; Zhang H; Guo X; Qin R
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via PI3K/AKT/mTOR signaling.
    Cui J; Guo Y; Wu H; Xiong J; Peng T
    Mol Med; 2021 Apr; 27(1):38. PubMed ID: 33849427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of novel chitosan-targeted gemcitabine nanomedicine mediating cisplatin on epithelial mesenchymal transition, invasion and metastasis of pancreatic cancer cells.
    Yu H; Song H; Xiao J; Chen H; Jin X; Lin X; Pan B; Ji W
    Biomed Pharmacother; 2017 Dec; 96():650-658. PubMed ID: 29035831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways.
    Li Y; Xi Z; Chen X; Cai S; Liang C; Wang Z; Li Y; Tan H; Lao Y; Xu H
    Cell Death Dis; 2018 May; 9(5):538. PubMed ID: 29749405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
    Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
    Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local Delivery of Gemcitabine Inhibits Pancreatic and Cholangiocarcinoma Tumor Growth by Promoting Epidermal Growth Factor Receptor Degradation.
    Jang SI; Fang S; Baek YY; Lee DH; Na K; Lee SY; Lee DK
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer.
    Sun Y; Ren D; Zhou Y; Shen J; Wu H; Jin X
    Cell Death Dis; 2021 Sep; 12(10):878. PubMed ID: 34564701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expression.
    Zhu J; Zhao J; Luo C; Zhu Z; Peng X; Zhu X; Lin K; Bu F; Zhang W; Li Q; Wang K; Hu Z; Yu X; Chen L; Yuan R
    Cell Death Dis; 2022 May; 13(5):497. PubMed ID: 35614040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory Effect of Oat Bran Ethanol Extract on Survival and Gemcitabine Resistance of Pancreatic Cancer Cells.
    Kim M; Mun JG; Lee HJ; Son SR; Lee MJ; Kee JY
    Molecules; 2019 Oct; 24(21):. PubMed ID: 31652886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreatic cancer through JAK2/STAT3 pathway.
    Liu Y; Bi T; Liu L; Gao Q; Shen G; Qin L
    Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):615-622. PubMed ID: 30683944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine.
    Dai S; Peng Y; Zhu Y; Xu D; Zhu F; Xu W; Chen Q; Zhu X; Liu T; Hou C; Wu J; Miao Y
    Biomed Pharmacother; 2020 Jan; 121():109521. PubMed ID: 31689601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.
    Kawaguchi K; Miyake K; Han Q; Li S; Tan Y; Igarashi K; Lwin TM; Higuchi T; Kiyuna T; Miyake M; Oshiro H; Bouvet M; Unno M; Hoffman RM
    Cell Cycle; 2018; 17(7):868-873. PubMed ID: 29623758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-15b promotes epithelial-mesenchymal transition by inhibiting SMURF2 in pancreatic cancer.
    Zhang WL; Zhang JH; Wu XZ; Yan T; Lv W
    Int J Oncol; 2015 Sep; 47(3):1043-53. PubMed ID: 26166038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response and EGFR-Akt pathway modulation.
    Ricciardiello F; Gang Y; Palorini R; Li Q; Giampà M; Zhao F; You L; La Ferla B; De Vitto H; Guan W; Gu J; Zhang T; Zhao Y; Chiaradonna F
    Oncogene; 2020 May; 39(20):4103-4117. PubMed ID: 32235891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARP14 promotes the proliferation and gemcitabine chemoresistance of pancreatic cancer cells through activation of NF-κB pathway.
    Yao N; Chen Q; Shi W; Tang L; Fu Y
    Mol Carcinog; 2019 Jul; 58(7):1291-1302. PubMed ID: 30968979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.